| Execution period | 4 years |
|---|
NSE filing, NSE: MASTERTR. Summary written from the filing by ALFA Finder's alert engine.
Master Trust Ltd: key numbers
- Share price
- ₹76.27
- Market cap
- ₹938.2 Cr
- Revenue (annual)
- ₹575.8 Cr
- Net profit (annual)
- ₹126.0 Cr
- P/E (TTM)
- 7.0×Sector 19.7×
- Promoter holding
- 71.93%+0.00% QoQ
- FII holding
- 0.31%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Master Trust Ltd
All →Master Trust Board Meeting Date
Master Trust Ltd intimated its Board meeting scheduled for 03 Nov 2026 to approve Q1/H1 un-audited financial results. No financial figures are disclosed in this advance notice.
Master Trust Business Update
Master Trust Limited’s subsidiary, Master Capital Services Limited, has commenced clearing and settlement services for F&O trades on NSE and BSE, effective October 15, 2026.
Master Trust Capacity Expansion
Master Capital Services Ltd, a wholly owned subsidiary of Master Trust Ltd, commenced F&O clearing and settlement services on NSE and BSE effective 15 October 2026. No monetary value is disclosed.
Master Trust Other Announcement
Master Trust Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI regulations.
Master Trust Acquisition Worth ₹0.5 Cr
Master Trust Limited acquired 100% of Future Colonizers & Construction Limited for ₹0.50 Crore via an NCLT-approved resolution plan under the Insolvency and Bankruptcy Code.
- Value
- ₹0.50 Cr
Master Trust Employee Stock Options
Master Trust Limited has granted 3,15,100 stock options to eligible employees under its Employee Stock Option Plan 2025. These options vest over four years.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date